Attachment L-9.1 Non-FCP Compliant List.xlsx

11 KB Posted

Attached to
DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5)
Solicitation number
HT940220R0002
Issued by

About this file

Written by GovTribe AI ·

This document contains a draft request for proposals for the Defense Health Agency's TRICARE Pharmacy Services, 5th Generation contract and a related federal contract opportunity notice. The draft RFP outlines an 18-month transition period, seven 1-year option periods for pharmacy services delivery, and a potential 6-month extension. The notice seeks industry feedback on requirements including specialty pharmacy, retail network access, compounded medications, care coordination, and patient safety notification. Interested vendors should submit any questions or comments on the draft RFP by January 17, 2020. The agency estimates a formal solicitation may be issued in mid-2020. The contract would provide fixed unit price pharmacy benefits to TRICARE beneficiaries.

View the file

Other files

File Type Posted
DSADHA_SSVTemplate_20170101.pdf PDF
QA CAS Applicability Specific Clauses (May 15 2020).pdf PDF
Responses to Industry on Revised Draft Section C 20200504.pdf PDF
TPharm5 - Overview of Changes to Draft Section C.DOCX DOCX document
TPharm5 Section C Draft RFP2 2020-4-6.docx DOCX document
DHA Responses to Industry on Draft RFP 20200318.pdf PDF
TPharm5 Draft RFP Info Session 20191211.pdf PDF
Data Pkg 2 - Retail Utilization by Drug.xlsx XLSX spreadsheet
Attachment L-9.8 PA_ST_QL List.XLSX XLSX spreadsheet
Data Pkg 15 IHS_Pharmacy_Claims_Volume_2017_&_2018.xlsx XLSX spreadsheet
Data Pkg 3 TRICARE Retail Pharmacy Claim Volume.xlsx XLSX spreadsheet
Attachment L-9.4 Covered OTC List - MHS GENESIS.xlsx XLSX spreadsheet
Attachment L-10 Small Business Participation Plan.docx DOCX document
TPharm5 Draft Section J 20191127.docx DOCX document
Data Pkg 8 Mail and Retail Monthly Utilizers.xlsx XLSX spreadsheet
Attachment J-1 Definitions.DOCX DOCX document
TPharm5 Draft Section M 20191202.docx DOCX document
Attachment L-9.6 Self-Admin Injectables List.xlsx XLSX spreadsheet
Attachment L-19 Past Performance Questionnaire Template Tab F 20191120.docx DOCX document
Attachment L-3 Specialty Reimbursement for Use in Determining Incentiv....docx DOCX document
Attachment L-9 Benefit Design Document_TPharm5.xlsx XLSX spreadsheet
Data Pkg 14 Retail Claims with COB.xlsx XLSX spreadsheet
Attachment L-9.5 Non-Formulary List.xlsx XLSX spreadsheet
Data Pkg 5 MOP Utilization by Drug.xlsx XLSX spreadsheet
Data Pkg 25 - OHI Development.xlsx XLSX spreadsheet
Data Pkg 22 - Paid Claims and Rejects - Retail.xlsx XLSX spreadsheet
TPharm5 Draft Section C 20191202.docx DOCX document
Attachment L-5 Guaranty_Agreement.pdf PDF
Data Pkg 6 - MOP Utilization.xlsx XLSX spreadsheet
Attachment L-13 VA_Pharmacy_Listing_2019.xlsx XLSX spreadsheet
Data Pkg 19 Historical_TMDS_Volume_2017-2018.xlsx XLSX spreadsheet
Attachment L-1.1 List of Data Packages.docx DOCX document
Data Pkg 13 - MTF Claims Volumes by Site.xlsx XLSX spreadsheet
TPharm5 Draft Section I 20191120.docx DOCX document
Attachment L-19.1 PPI Tool Instructions.docx DOCX document
Attachment L-9.3 Covered OTCs - Purchased Care.xlsx XLSX spreadsheet
Attachment J-5 TPharm5 Award Fee Plan 20191122.docx DOCX document
TPharm5 Draft Section D 20191120.docx DOCX document
Attachment L-12 IHS_Pharmacy_Listing_2019.xlsx XLSX spreadsheet
TPharm5 Draft Section E 20191120.docx DOCX document
Attachment L-18 CDRL Supplemental Bid Schedule.xlsx XLSX spreadsheet
Data Pkg 7 Specialty Drug Utilization, Retail and Mail.xlsx XLSX spreadsheet
Data Pkg 16 VA_VA CHDR Volume.xlsx XLSX spreadsheet
TPharm5 Draft Section H 20191121.docx DOCX document
Attachment L-7 Teaming Subcontractor Consent Ltr.docx DOCX document
Attachment L-2 Retail Network Reimbursement Table.docx DOCX document
Attachment L-4 Negotiated Specialty Retail Replenished Dispensing Fees.docx DOCX document
Tpharm5 Draft Section G 20191202.docx DOCX document
Data Pkg 10 - Compound Utilizers.xlsx XLSX spreadsheet
TPharm5 Draft Section F 20191202.docx DOCX document
Show 40 more

Latest 50 of 73 listed here. See the rest on GovTribe.

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Sheet1 FDB GCN NDC11 TRADE NAME STRENGTH DESC GCDF DESC ROUTE DESC FORMULARY STATUS F=LEGEND

I=INSULIN

O=OTCSUBCODEPACK SIZEMANUFACTURER NAMERule Name
1056154396011111OXANDRIN2.5 MGTABLETORALNFMulti-Source Brand100SAVIENT PHARMACNON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
1798858487000101DURLAZA162.5 MGCAPSULE, EXT RELEASE 24 HRORALNFBrand30NEW HAVEN PHARMNON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
1816000067434504TRANSDERM-SCOP1 MG/3 DAYPATCH,TRANSDERMAL 3 DAYTRANSDERMALNFMulti-Source Brand4NOVARTIS CONSUMNON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
1826554396011060OXANDRIN10 MGTABLETORALNFMulti-Source Brand60SAVIENT PHARMACNON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
2632060846080601UNITHROID112 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
2632160846080101UNITHROID25 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
2632260846080201UNITHROID50 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
2632360846080501UNITHROID100 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
2632460846080301UNITHROID75 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
2632560846081101UNITHROID200 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
2632660846080701UNITHROID125 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
2632760846080901UNITHROID150 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
2632860846081001UNITHROID175 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
2632960846081201UNITHROID300 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
3608259651004730ARMODAFINIL200 MGTABLETORALNFGeneric30AUROBINDO PHARMNON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
3852069076091302MERCAPTOPURINE50 MGTABLETORALNFGeneric25QUINN PHARMACEUNON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
3852069076091325MERCAPTOPURINE50 MGTABLETORALNFGeneric250QUINN PHARMACEUNON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
4763160846080401UNITHROID88 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
4763260846080801UNITHROID137 MCGTABLETORALNFGeneric100GEMINI LABORATONON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
9807670839030030TEKTURNA300 MGTABLETORALNFMulti-Source Brand30NODEN PHARMA D.NON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
9807770839015030TEKTURNA150 MGTABLETORALNFMulti-Source Brand30NODEN PHARMA D.NON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
9931070839011230TEKTURNA HCT150-12.5MGTABLETORALNFBrand30NODEN PHARMA D.NON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
9931170839012530TEKTURNA HCT150MG-25MGTABLETORALNFBrand30NODEN PHARMA D.NON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
9931270839031230TEKTURNA HCT300-12.5MGTABLETORALNFBrand30NODEN PHARMA D.NON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED
9931370839032530TEKTURNA HCT300MG-25MGTABLETORALNFBrand30NODEN PHARMA D.NON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED

File details come from the government source that posted it. Updated .